Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bovie Medical Corp (BVX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 215,136
  • Shares Outstanding, K 33,200
  • Annual Sales, $ 38,880 K
  • Annual Income, $ -5,060 K
  • 60-Month Beta -0.27
  • Price/Sales 5.47
  • Price/Cash Flow N/A
  • Price/Book 2.36
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings -0.01 on 11/01/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.10
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.89 +32.52%
on 12/20/18
7.70 -15.84%
on 12/11/18
-0.59 (-8.35%)
since 11/30/18
3-Month
4.82 +34.44%
on 10/23/18
7.70 -15.84%
on 12/11/18
-0.62 (-8.73%)
since 09/28/18
52-Week
2.28 +184.21%
on 03/12/18
7.70 -15.84%
on 12/11/18
+3.88 (+149.23%)
since 12/29/17

Most Recent Stories

More News
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 13, 2019

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical...

APYX : 7.81 (+1.56%)
BVX : 6.48 (+1.09%)
Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2018 Revenue Results

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical...

APYX : 7.81 (+1.56%)
BVX : 6.48 (+1.09%)
Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan

Conatus (CNAT) concentrates on the development of its lead candidate emricasan for treating patients with fibrosis or cirrhosis caused by NASH.

CNAT : 2.87 (-0.69%)
BVX : 6.48 (+1.09%)
NVS : 92.99 (-0.19%)
PFE : 42.30 (+1.17%)
Has Bovie Medical (BVX) Outpaced Other Medical Stocks This Year?

Is (BVX) Outperforming Other Medical Stocks This Year?

BVX : 6.48 (+1.09%)
Bovie Medical Corporation Files 510(k) Submission with the FDA for a New Indication to Market and Sell J-Plasma/Renuvion for Use in Dermal Resurfacing Procedures

Bovie Medical Corporation (NYSE:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the Renuvion(R)...

BVX : 6.48 (+1.09%)
Bovie Medical Corporation Announces Appointment of Tara H. Semb as Chief Financial Officer

Bovie Medical Corporation (NYSE:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the Renuvion(R)...

BVX : 6.48 (+1.09%)
Bovie Medical Corporation Announces Corporate Name Change to Apyx Medical Corporation and Plans to Transition Common Stock Listing to NASDAQ Global Select Market

Bovie Medical Corporation (NYSE:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical product marketed and sold under the Renuvion(R)...

SSRG : 13.18 (+0.38%)
BVX : 6.48 (+1.09%)
Quidel (QDEL) Catches Eye: Stock Jumps 6.7%

Quidel (QDEL) shares rose nearly 7% in the last trading session, amid huge volumes.

BVX : 6.48 (+1.09%)
QDEL : 67.39 (-0.35%)
Why Varex Imaging (VREX) Could Be Positioned for a Slump

Varex Imaging (VREX) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

BVX : 6.48 (+1.09%)
VREX : 34.25 (+3.98%)
Conatus' Emricasan Misses Primary Endpoint in Mid-Stage Study

Conatus' (CNAT) emricasan fails to meet the primary endpoint in a phase IIb study on compensated NASH cirrhosis patients at high risk of decompensation.

CNAT : 2.87 (-0.69%)
BVX : 6.48 (+1.09%)
NVS : 92.99 (-0.19%)
PFE : 42.30 (+1.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BVX with:

Business Summary

Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devicesand advanced coating technologies.

See More

Key Turning Points

2nd Resistance Point 6.87
1st Resistance Point 6.68
Last Price 6.48
1st Support Level 6.32
2nd Support Level 6.15

See More

52-Week High 7.70
Last Price 6.48
Fibonacci 61.8% 5.63
Fibonacci 50% 4.99
Fibonacci 38.2% 4.35
52-Week Low 2.28

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar